Jaydess

Levonorgestrel, the active ingredient in Jaydess, is a Progestogen presented as a 13.5 mg intrauterine system for intrauterine use. It provides hormonal contraception for women of reproductive age, preventing pregnancy for up to three years. GNH USA supplies Jaydess as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jaydess is a levonorgestrel intrauterine system used in hormonal contraception to prevent pregnancy. - Contraception: provides up to three years of highly effective pregnancy prevention in women seeking long‑acting reversible contraception.

Jaydess may cause a range of adverse reactions, most of which are mild and resolve over time.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) - Pelvic or cramping pain after insertion - Insertion‑site discomfort - Headache - Breast tenderness

Serious or Rare Side Effects: - Uterine perforation during insertion - Device expulsion or migration - Pelvic inflammatory infection - Ectopic pregnancy if contraception fails - Ovarian cyst formation - Severe allergic reaction (anaphylaxis)

Before prescribing Jaydess, clinicians should evaluate patient suitability and counsel on expected outcomes. - Assess uterine cavity: confirm appropriate size and shape for IUS placement - Screen for pregnancy: ensure patient is not pregnant before insertion - Review contraindications: active pelvic infection, unexplained vaginal bleeding, or known hypersensitivity to levonorgestrel - Counsel on bleeding pattern: inform that irregular bleeding is common during the first months - Monitor for infection: advise prompt medical attention for fever or unusual discharge after insertion - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel IUS has limited systemic exposure, yet certain drugs can affect its contraceptive efficacy.

Major Interactions (Avoid): - Rifampin and other strong CYP3A4 inducers: may significantly reduce levonorgestrel effectiveness - Certain antiepileptic drugs (e.g., carbamazepine, phenytoin): can lower hormone levels

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may modestly decrease efficacy - Antiretroviral agents (e.g., efavirenz): potential reduction in contraceptive effect - St. John’s wort: may slightly reduce hormone exposure - Anticoagulants (e.g., warfarin): may increase risk of bleeding at insertion site